Sort
30,917 grants matching “tumor microenvironment”
In situ anti-tumor immunity and effects of radiation
$246,421Edith M. Lord · University Of Rochester · R01 · FY2007 · CA
In situ anti-tumor immunity and effects of radiation
$246,421Edith M. Lord · University Of Rochester · R01 · FY2009 · CA
In situ anti-tumor immunity and effects of radiation
$246,421Edith M. Lord · University Of Rochester · R01 · FY2008 · CA
Bacteria-Based MR Molecular Imaging of Tumor Oxygenation
$246,396University Of Pittsburgh At Pittsburgh · R21 · FY2003 · EB
Core B: Liver Metastasis Resource Core (LMRC)
$246,376Edwin Melencio Posadas · Cedars-Sinai Medical Center · P01 · FY2022 · CA
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer
$246,369Christopher J. Halbrook · University Of California-Irvine · R00 · FY2022 · CA
The role of bone marrow macrophages in skeletal metastasis
$246,260Laurie K. McCauley · University Of Michigan At Ann Arbor · P01 · FY2017 · CA
Reviving cancer immune surveillance with CD4 T cell help
$246,243Michael Clavon Brown · Duke University · R00 · FY2023 · CA
Cancer Center Support Grant 2018-2023
$246,238Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2019 · CA
Pharmacologic /Genetic Inhibition of XBP1 as Hypoxia Targeted Therapeutic Strateg
$246,206Albert Koong · Stanford University · P01 · FY2011 · CA
The Tumor Microenvironmental Barrier to Effective Viral Oncolysis
$246,137Balveen Kaur · Ohio State University · P01 · FY2015 · CA
Small Molecule CUL4 Inhibitors as Dual Precision Oncology and Immuno-Oncology Drugs
$246,118Pengbo Zhou · Culnexin Therapeutics, Inc. · R41 · FY2022 · CA
Project 3: HHLA2 as a THerapeutic Target in RCC
$246,071David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2022 · CA
The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival
$246,053Lauren Cole Peres · H. Lee Moffitt Cancer Ctr & Res Inst · R00 · FY2018 · CA
Mesenchymal Derived Growth Factors in Prostatic Cancer
$246,042David R Rowley · Baylor College Of Medicine · R01 · FY2013 · CA
Nanoparticle-augmented image-guided CAR T therapy and post-treatment assessment
$246,022Jinhwan Kim · University Of California At Davis · R00 · FY2024 · CA
Method Development: Efficient Computer Vision Based Algorithms
$246,016Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
USC Norris Comprehensive Cancer Center (CORE) Support
$246,000Stephen B Gruber · University Of Southern California · P30 · FY2012 · CA
An Engineered CRISPR System for Boosting Tumor Immunogenicity.
$246,000Weixin Tang · University Of Chicago · R21 · FY2021 · EB
An Engineered CRISPR System for Boosting Tumor Immunogenicity.
$246,000Weixin Tang · University Of Chicago · R21 · FY2022 · EB
Identification of BATF function and targets during NK cell activation
$246,000Barbara Lynne Kee · University Of Chicago · R21 · FY2022 · AI
Application of PPG Technology and Previous Results to Human Breast Tumors
$245,932John S Condeelis · Albert Einstein College Of Medicine · P01 · FY2012 · CA
Aged tissue environments as drivers of oncogenic adaptation in hematopoiesis
$245,862James V Degregori · University Of Colorado Denver · R01 · FY2023 · AG
Obesity associated inflammation and postmenopausal breast cancer.
$245,842Erin Giles · Texas A&M Agrilife Research · R00 · FY2018 · CA
The Epidemiology of Immune Responses in Colorectal Cancer
$245,832Stephen B Gruber · University Of Southern California · R01 · FY2019 · CA